Gabelli Funds LLC decreased its holdings in ICU Medical, Incorporated (NASDAQ:ICUI) by 5.0% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 43,700 shares of the medical instruments supplier’s stock after selling 2,300 shares during the quarter. Gabelli Funds LLC owned 0.21% of ICU Medical worth $12,356,000 as of its most recent filing with the SEC.
Other large investors have also added to or reduced their stakes in the company. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of ICU Medical in the second quarter worth $235,000. Legal & General Group Plc boosted its stake in ICU Medical by 18.1% during the second quarter. Legal & General Group Plc now owns 17,686 shares of the medical instruments supplier’s stock valued at $5,193,000 after buying an additional 2,706 shares in the last quarter. Smith Asset Management Group LP boosted its stake in ICU Medical by 1,207.6% during the second quarter. Smith Asset Management Group LP now owns 38,745 shares of the medical instruments supplier’s stock valued at $11,377,000 after buying an additional 35,782 shares in the last quarter. Baird Financial Group Inc. boosted its stake in ICU Medical by 0.5% during the second quarter. Baird Financial Group Inc. now owns 49,781 shares of the medical instruments supplier’s stock valued at $14,618,000 after buying an additional 245 shares in the last quarter. Finally, Cubist Systematic Strategies LLC bought a new position in ICU Medical during the second quarter valued at about $5,849,000. 73.51% of the stock is owned by institutional investors.
In other news, Director Pfizer Inc sold 700,000 shares of the company’s stock in a transaction on Monday, August 13th. The stock was sold at an average price of $284.35, for a total transaction of $199,045,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Virginia Ruth Sanzone sold 787 shares of the company’s stock in a transaction on Tuesday, August 28th. The shares were sold at an average price of $303.12, for a total value of $238,555.44. Following the sale, the vice president now directly owns 1,367 shares of the company’s stock, valued at $414,365.04. The disclosure for this sale can be found here. Insiders have sold 711,920 shares of company stock valued at $202,651,956 in the last ninety days. Company insiders own 12.50% of the company’s stock.
ICUI has been the subject of several research reports. TheStreet raised ICU Medical from a “c+” rating to a “b+” rating in a research note on Monday, August 20th. ValuEngine cut ICU Medical from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 3rd. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday, September 28th. Finally, Zacks Investment Research cut ICU Medical from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 11th.
Shares of ICUI stock opened at $232.01 on Friday. ICU Medical, Incorporated has a fifty-two week low of $196.33 and a fifty-two week high of $321.70. The stock has a market cap of $5.31 billion, a P/E ratio of 35.99 and a beta of 0.65.
ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, November 8th. The medical instruments supplier reported $1.85 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.34. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. The business had revenue of $327.20 million during the quarter, compared to analysts’ expectations of $334.97 million. During the same quarter last year, the business posted $1.12 earnings per share. The company’s quarterly revenue was down 4.7% on a year-over-year basis. On average, equities analysts forecast that ICU Medical, Incorporated will post 7.6 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “ICU Medical, Incorporated (ICUI) Stake Lessened by Gabelli Funds LLC” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/11/10/icu-medical-incorporated-icui-stake-lessened-by-gabelli-funds-llc.html.
ICU Medical Company Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Featured Article: Why do companies issue stock splits?
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.